Receive Registration Certifications in China T.BHC Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets
LAVAL, QC / ACCESSWIRE / January 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and Solta Medical, a global leader in the medical aesthetics market, today announced the approval of Thermage® FLX and the TR-4 Return Pad by China's National Medical Products Administration (NMPA). The TR-4 Return Pad is not approved for use by the U.S. Food & Drug Administration.
Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China (accesswire.com)